
Please try another search
DreamCIS, Inc. provides clinical research services in South Korea. It offers clinical development services; biostatic, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.
Name | Age | Since | Title |
---|---|---|---|
Hao Wu | 58 | 2025 | Non-Executive Director |
NamHun Kim | 44 | - | Independent Outside Director |
Chengzhe Jin | 42 | 2025 | Non-Executive Director |
Taesik Yang | 56 | 2016 | CFO & Executive Director |
TaeUk Yang | 52 | 2020 | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review